glucagon has been researched along with drf 2725 in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (drf 2725) | Trials (drf 2725) | Recent Studies (post-2010) (drf 2725) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 41 | 3 | 4 |
| Protein | Taxonomy | glucagon (IC50) | drf 2725 (IC50) |
|---|---|---|---|
| Chain A, peroxisome proliferator activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.98 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roden, M; Stingl, H | 1 |
1 review(s) available for glucagon and drf 2725
| Article | Year |
|---|---|
[Future targets in the treatment of type 2 diabetes].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycated Hemoglobin; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Peroxidation; Metabolic Syndrome; Mice; Oxazines; Peptide Fragments; Phenylpropionates; Protein Precursors; Rats; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors | 2004 |